https://www.ema.europa.eu/en/medicines/human/EPAR/beqvez
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/pomalidomide-zentiva
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/apexelsin
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/theralugand
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/winrevair
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/eurneffy
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/mresvia
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/balversa
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/piasky
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/tauvid
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/akantior
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ordspono
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/enzalutamide-viatris
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/nilotinib-accord
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/wezenla
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/fruzaqla
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/tofidence
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/buprenorphine-neuraxpharm
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/tuznue
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/vevizye
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ituxredi
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/epruvy
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/sotatercept
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/ivosidenib
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/jakavi-5-mg-comprime
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/rybrevant
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/concizumab
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/dabrafenib
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/trametinib
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/imcivree#
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/teclistamab
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/enhertu-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/imfinzi-50-mg-ml-solution-a-diluer-pour-perfusion
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/kimozo-40-mg-ml-suspension-buvable#
2025
false
false
false
---
https://ansm.sante.fr/tableau-marr/rivaroxaban
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/rybrevant
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/axitinib-accord
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/loqtorzi
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/anzupgo
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/vyloy
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/kayfanda
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/iqirvo
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/hympavzi
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/truqap
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/altuvoct
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/flucelvax
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/elahere
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/pomalidomide-teva
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/alhemo
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/afqlir
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/opuviz
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/eltrombopag-viatris
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/imuldosa
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/absimky
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/eksunbi
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/fluenz
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/galliapharm
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/agilus
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/welireg
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/rezurock#
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/koselugo
2025
false
false
false
---
https://ansm.sante.fr/informations-de-securite/ambisome-liposomal-50-mg-et-fungizone-50-mg-injectable-attention-ces-deux-specialites-ne-sont-pas-interchangeables
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/zanidatamab
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/nirogacestat
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/vyjuvek
2025
false
false
false
---
https://ansm.sante.fr/actualites/decision-du-07-02-2025-portant-exoneration-a-la-reglementation-des-substances-veneneuses-destinees-a-la-medecine-humaine
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/penbraya
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/vimkunya
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/paxneury
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/lazcluze
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/kavigale
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/yesintek
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/siiltibcy
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/baiama
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/gohibic
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/augtyro
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ahzantive
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/eydenzelt
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/emcitate
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/zefylti
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/obodence
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/nemluvio
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/korjuny
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/andembry
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/beyonttra
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/rytelo
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/wainzua
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/hetronifly
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ixchiq
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/yuvanci
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/obgemsa
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/eribulin-baxter
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/pomalidomide-accord
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/avzivi
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/dasatinib-accord-healthcare
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/fymskina
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/otulfi
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/pomalidomide-krka
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/cejemly
2025
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/zegalogue
2025
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/jemperli
2024
false
false
false
---
https://ansm.sante.fr/actualites/quelle-information-sur-les-dispositifs-medicaux-contenant-du-cobalt
2024
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/niraparib-acetate-dabiraterone
2024
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/bylvay
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/vueway
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/elucirem
2024
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/scemblix-20-mg-40-mg-comprimes-pellicules
2024
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/dupixent
2024
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/breyanzi
2024
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/ciclograft-20mg-ml-collyre-en-solution-en-recipient-unidose
2024
false
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/libmyris
2024
false
false
false
---
2024
false
false
false
---
https://ansm.sante.fr/tableau-marr/ranibizumab
2024
false
false
false
---
https://www.ema.europa.eu/medicines/human/EPAR/Metalyse
2024
false
---
https://ansm.sante.fr/tableau-atu-rtu/kymriah-1-2-x-106-6-x-108-cellules-dispersion-pour-perfusion
2024
false
false
false
---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
---
https://ansm.sante.fr/actualites/lansm-publie-son-rapport-dhemovigilance-de-lannee-2023
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/adzynma
2024
false
false
false
---
https://ansm.sante.fr/tableau-marr/sulfate-de-sodium-anhydre-sulfate-de-magnesium-heptahydrate-sulfate-de-potassium
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/steqeyma
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/rezzayo
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/yesafili
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/inaqovi
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/orserdu
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ebglyss
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/herwenda
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/aqumeldi
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/jaypirca
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/degarelix-accord
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/tyruko
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/tepkinly
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/lyfnua
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/tevimbra
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/enrylaze
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/tyenne
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/apretude
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/talvey
2024
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/irenat
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/elrexfio
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/zilbrysq
2024
false
false
false
---
https://www.has-sante.fr/jcms/p_3515581/fr/finlee-spexotras-dabrafenib-trametinib-gliome-pediatrie
2024
false
false
false
---
https://www.has-sante.fr/jcms/p_3516966/fr/loargys-pegzilarginase-deficit-en-arginase-1
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/spexotras
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/finlee
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/rystiggo
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/loargys
2024
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/fabhalta
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/pyzchiva
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/skyclarys
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/jubbonti
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/filspari
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/awiqli
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/omlyclo
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/lytenava
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/dabigatran-etexilate-leon-farma
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/tizveni
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/apremilast-accord
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/voydeya
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ibuprofen-genorph
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ryzneuta
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/emblaveo
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/incellipan
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/celldemic
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/zynyz-0
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/nintedanib-accord
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/veoza
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/niapelf
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/exblifep
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/casgevy
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/pomalidomide-viatris
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/naveruclif
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/velsipity
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/mevlyq
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/uzpruvo
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/rimmyrah
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/azacitidine-kabi
2024
false
false
false
---
https://ansm.sante.fr/informations-de-securite/nouvelles-conditions-de-prescription-et-de-delivrance-des-specialites-a-base-dacetate-de-medroxyprogesterone-depo-provera-150-mg-3-ml-et-de-medrogestone-colprone-5-mg-liees-au-risque-de-meningiome-a-compter-du-1er-juillet-2024
2024
false
false
false
---
https://ansm.sante.fr/tableau-marr/ranibizumab-3
2024
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/beremagene-geperpavec
2024
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/blincyto
2024
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/qdenga
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/livmarli
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/teriparatide-sun
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/pyrukynd
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ebvallo
2023
false
false
false
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-la-covid-19-periode-du-22-12-2022-au-19-01-2023
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/xenpozyme
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/celdoxome-pegylated-liposomal
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/zynlonta
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/pemetrexed-baxter
2023
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/nexviadyme-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2023
false
false
false
---
https://ansm.sante.fr/tableau-atu-rtu/sotorasib-120-mg-comprimes-pellicules
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/eladynos
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/vanflyta-0
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/ryeqo
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/spevigo
2023
false
false
false
---
https://www.ema.europa.eu/en/medicines/human/EPAR/plerixafor-accord
2023
false
false
false
---
https://ansm.sante.fr/actualites/arret-de-commercialisation-du-medicament-josacine-josamycine
2023
false
false
false
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-contre-le-covid-19-periode-du-13-01-2023-au-16-02-2023
2023
false
false
false
---
https://ansm.sante.fr/tableau-acces-derogatoire/natriumthiosulfat-10-solution-pour-perfusion-natriumthiosulfat-25-solution-pour-perfusion
2023
false
false
false
---
